Zhangzhou Pientzehuang Pharmaceutical., Ltd (600436.SS)
CNY 220.76
(0.79%)
CNY 220.76
(0.79%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 1.3 Billion CNY | 16.69% |
| 2022 | 1.1 Billion CNY | -14.37% |
| 2021 | 1.29 Billion CNY | 16.37% |
| 2020 | 1.1 Billion CNY | 17.03% |
| 2019 | 948.03 Million CNY | 23.25% |
| 2018 | 769.2 Million CNY | 9.32% |
| 2017 | 703.61 Million CNY | 34.54% |
| 2016 | 522.98 Million CNY | 43.58% |
| 2015 | 364.24 Million CNY | 27.08% |
| 2014 | 286.63 Million CNY | 9.69% |
| 2013 | 261.3 Million CNY | 18.52% |
| 2012 | 220.47 Million CNY | 38.77% |
| 2011 | 158.87 Million CNY | 20.21% |
| 2010 | 132.16 Million CNY | 18.76% |
| 2009 | 111.28 Million CNY | -3.22% |
| 2008 | 114.98 Million CNY | 30.31% |
| 2007 | 88.23 Million CNY | 19.2% |
| 2006 | 74.02 Million CNY | -11.31% |
| 2005 | 83.46 Million CNY | -14.32% |
| 2004 | 97.41 Million CNY | 58.07% |
| 2003 | 61.62 Million CNY | 28.48% |
| 2002 | 47.96 Million CNY | 14.52% |
| 2001 | 41.88 Million CNY | 24.54% |
| 2000 | 33.63 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 217.65 Million CNY | -88.32% |
| 2024 Q2 | 1.59 Billion CNY | 377.99% |
| 2024 Q1 | 333.65 Million CNY | -39.53% |
| 2023 Q2 | 208.68 Million CNY | -42.07% |
| 2023 Q3 | 313.95 Million CNY | 50.44% |
| 2023 FY | 1.29 Billion CNY | 16.69% |
| 2023 Q1 | 360.22 Million CNY | 5.99% |
| 2023 Q4 | 551.72 Million CNY | 75.73% |
| 2022 FY | 1.1 Billion CNY | -14.37% |
| 2022 Q4 | 339.88 Million CNY | 85.26% |
| 2022 Q1 | 347.33 Million CNY | -15.6% |
| 2022 Q2 | 234.83 Million CNY | -32.39% |
| 2022 Q3 | 183.46 Million CNY | -21.88% |
| 2021 FY | 1.29 Billion CNY | 16.37% |
| 2021 Q1 | 296.93 Million CNY | 37.11% |
| 2021 Q4 | 411.52 Million CNY | 58.77% |
| 2021 Q3 | 259.19 Million CNY | -19.86% |
| 2021 Q2 | 323.43 Million CNY | 8.93% |
| 2020 Q2 | 249.46 Million CNY | -10.79% |
| 2020 Q3 | 363.76 Million CNY | 45.82% |
| 2020 Q4 | 216.56 Million CNY | -40.47% |
| 2020 FY | 1.1 Billion CNY | 17.03% |
| 2020 Q1 | 279.64 Million CNY | -2.92% |
| 2019 Q4 | 288.06 Million CNY | 22.68% |
| 2019 Q3 | 234.8 Million CNY | 5.86% |
| 2019 FY | 948.03 Million CNY | 23.25% |
| 2019 Q1 | 203.36 Million CNY | -14.33% |
| 2019 Q2 | 221.79 Million CNY | 9.06% |
| 2018 FY | 769.2 Million CNY | 9.32% |
| 2018 Q1 | 185.63 Million CNY | -23.89% |
| 2018 Q3 | 157.05 Million CNY | -16.96% |
| 2018 Q4 | 237.38 Million CNY | 51.15% |
| 2018 Q2 | 189.13 Million CNY | 1.88% |
| 2017 Q1 | 134.87 Million CNY | -29.39% |
| 2017 Q4 | 243.91 Million CNY | 46.7% |
| 2017 Q2 | 158.55 Million CNY | 17.56% |
| 2017 FY | 703.61 Million CNY | 34.54% |
| 2017 Q3 | 166.26 Million CNY | 4.86% |
| 2016 Q1 | 99.49 Million CNY | -19.4% |
| 2016 Q4 | 191.02 Million CNY | 53.68% |
| 2016 Q3 | 124.29 Million CNY | 14.91% |
| 2016 Q2 | 108.16 Million CNY | 8.71% |
| 2016 FY | 522.98 Million CNY | 43.58% |
| 2015 Q2 | 76.35 Million CNY | 2.42% |
| 2015 FY | 364.24 Million CNY | 27.08% |
| 2015 Q4 | 123.44 Million CNY | 37.32% |
| 2015 Q3 | 89.89 Million CNY | 17.73% |
| 2015 Q1 | 74.55 Million CNY | -14.46% |
| 2014 Q4 | 87.15 Million CNY | 23.68% |
| 2014 FY | 286.63 Million CNY | 9.69% |
| 2014 Q1 | 66.2 Million CNY | -31.89% |
| 2014 Q3 | 70.46 Million CNY | 12.18% |
| 2014 Q2 | 62.81 Million CNY | -5.12% |
| 2013 Q1 | 54.38 Million CNY | -1.22% |
| 2013 Q2 | 54.53 Million CNY | 0.29% |
| 2013 Q3 | 55.18 Million CNY | 1.18% |
| 2013 Q4 | 97.19 Million CNY | 76.15% |
| 2013 FY | 261.3 Million CNY | 18.52% |
| 2012 Q4 | 55.05 Million CNY | 6.41% |
| 2012 Q3 | 51.73 Million CNY | -13.85% |
| 2012 Q2 | 60.05 Million CNY | 11.97% |
| 2012 Q1 | 53.63 Million CNY | 35.57% |
| 2012 FY | 220.47 Million CNY | 38.77% |
| 2011 Q4 | 39.56 Million CNY | 16.47% |
| 2011 FY | 158.87 Million CNY | 20.21% |
| 2011 Q3 | 33.96 Million CNY | -23.85% |
| 2011 Q2 | 44.6 Million CNY | 9.47% |
| 2011 Q1 | 40.74 Million CNY | 37.65% |
| 2010 FY | 132.16 Million CNY | 18.76% |
| 2010 Q3 | 34.98 Million CNY | -16.38% |
| 2010 Q2 | 41.83 Million CNY | 62.46% |
| 2010 Q4 | 29.59 Million CNY | -15.39% |
| 2010 Q1 | 25.74 Million CNY | -20.05% |
| 2009 Q4 | 32.2 Million CNY | 15.32% |
| 2009 Q2 | 31.82 Million CNY | 64.65% |
| 2009 Q1 | 19.32 Million CNY | -50.31% |
| 2009 Q3 | 27.92 Million CNY | -12.23% |
| 2009 FY | 111.28 Million CNY | -3.22% |
| 2008 Q3 | 21.97 Million CNY | -30.43% |
| 2008 Q4 | 38.89 Million CNY | 76.99% |
| 2008 FY | 114.98 Million CNY | 30.31% |
| 2008 Q1 | 22.53 Million CNY | -9.8% |
| 2008 Q2 | 31.58 Million CNY | 40.19% |
| 2007 Q4 | 24.97 Million CNY | 11.43% |
| 2007 Q3 | 22.41 Million CNY | 1.93% |
| 2007 Q2 | 21.99 Million CNY | 16.68% |
| 2007 Q1 | 18.84 Million CNY | -3.4% |
| 2007 FY | 88.23 Million CNY | 19.2% |
| 2006 Q3 | 19.37 Million CNY | -9.74% |
| 2006 Q4 | 19.51 Million CNY | 0.73% |
| 2006 Q2 | 21.46 Million CNY | 56.87% |
| 2006 FY | 74.02 Million CNY | -11.31% |
| 2006 Q1 | 13.68 Million CNY | -41.83% |
| 2005 FY | 83.46 Million CNY | -14.32% |
| 2005 Q4 | 23.52 Million CNY | 3.42% |
| 2005 Q3 | 22.74 Million CNY | -8.57% |
| 2005 Q2 | 24.87 Million CNY | 101.85% |
| 2005 Q1 | 12.32 Million CNY | -76.18% |
| 2004 Q4 | 51.74 Million CNY | 257.08% |
| 2004 Q2 | 22.41 Million CNY | 155.63% |
| 2004 FY | 97.41 Million CNY | 58.07% |
| 2004 Q1 | 8.76 Million CNY | -64.88% |
| 2004 Q3 | 14.48 Million CNY | -35.36% |
| 2003 Q3 | 10.13 Million CNY | -34.29% |
| 2003 Q2 | 15.42 Million CNY | 38.89% |
| 2003 Q4 | 24.97 Million CNY | 146.45% |
| 2003 FY | 61.62 Million CNY | 28.48% |
| 2003 Q1 | 11.1 Million CNY | -41.64% |
| 2002 FY | 47.96 Million CNY | 14.52% |
| 2002 Q4 | 19.02 Million CNY | 69.09% |
| 2002 Q3 | 11.25 Million CNY | 0.0% |
| 2001 FY | 41.88 Million CNY | 24.54% |
| 2000 FY | 33.63 Million CNY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Jiangsu Hengrui Medicine Co., Ltd. | 14.38 Billion CNY | 90.896% |
| Zhejiang CONBA Pharmaceutical Co.,Ltd. | 3.14 Billion CNY | 58.413% |
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. | 1.08 Billion CNY | -20.58% |
| Aurora Optoelectronics Co.,Ltd. | 482.31 Million CNY | -171.512% |
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd | 64.1 Million CNY | -1942.935% |
| NanJing Pharmaceutical Company Limited | 2.3 Billion CNY | 43.208% |
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. | 818.48 Million CNY | -59.997% |
| Tonghua Dongbao Pharmaceutical Co., Ltd. | 1.08 Billion CNY | -20.222% |